Zhejiang Beta Pharma Incorporation

Chine

Commandez votre montre hebdomadaire Zhejiang Beta Pharma Incorporation
Quantité totale PI 12
Rang # Quantité totale PI 129 999
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 707 690

Brevets

Marques

0 0
0 0
12 0
0
 
Dernier brevet 2012 - Compound for increasing kinase a...
Premier brevet 2009 - Icotinib hydrochloride, synthesi...

Derniers inventions, produits et services

2011 Invention Compound for increasing kinase active and application thereof. The compound of formula (I), pharm...
Invention Compounds for increase of hdl-c level and uses thereof. Compounds for inhibiting cholesterol este...
Invention Compounds for treatment of metabolic disorders. Compounds having activity as agonist of GPR119 an...
Invention Amids substituted indazole derivativees as ploy(adp-ribose)polymerase inhibitors. Amide substitut...
Invention Novel fused heterocyclic derivatives useful as c-met tyrosine kinase inhibitors. Certain novel fu...
Invention C-aryl glucoside sglt2 inhibitors and method. C-aryl glucosides which are inhibitors of sodium de...
Invention Glp-1 derivatives and uses thereof. A kind of glucagon-like peptide derivatives (GLP-1) having th...
Invention Glucagon-like peptide-1 analogue and use thereof. Provided is a glucagon-like peptide-1 (GLP-1) a...
2010 Invention Compounds and compositions as protein kinase inhibitors. The invention provides a novel class of ...
Invention Compounds as hypoxia mimetics, and compositions, and uses thereof. This invention relates to new ...
Invention Novel glucagon like peptide analogs, composition, and method of use. The present invention relate...
2009 Invention Icotinib hydrochloride, synthesis, crystallographic form, medical combination, and uses thereof. ...